Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASP study of antenatal magnesium sulfate to prevent cerebral palsy in preterm infants
2011-000735-80Phase 3Completed
- Sponsor
- Lene Drasbek Huusom
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of magnesium sulfate in cerebral palsy (CP) (2 arms), sponsored by Lene Drasbek Huusom. Primary endpoint: Moderate to severe cerebral palsy. Started Mar 2011; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on 2011-000735-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000735-80.